Aortic Dissection
Conditions
Brief summary
A single-center prospective study. Patients undergoing surgery for acute type A aortic dissection with femoral arterial cannulation between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden are eligible. Femoral cannulation was performed either with surgical cut-down and arterial puncture under direct vision or percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA, Essential Medical Inc., Malvern, Pennsylvania). Data regarding preoperative clinical characteristics and operative details were obtained by medical records review.
Interventions
Percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA, Essential Medical Inc., Malvern, Pennsylvania).
Surgical cut-down and arterial puncture under direct vision.
Sponsors
Study design
Eligibility
Inclusion criteria
* Operated for acute type A aortic dissection between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden.
Exclusion criteria
* Non-femoral arterial cannulation * Concomitant femoro-femoral bypass * Conversion to ECMO with arterial inflow in the previously cannulated femoral artery * Death within 30 days from procedure * Loss to follow-up
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Femoral access site complication | During the first 8 weeks after surgery | Seroma, wound infection, or nerve injury |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Femoral artery complication | During the first 3 years after surgery | Pseudoaneurysm, local dissection, stenosis, intermittent claudication, or vascular closure device failure |
Countries
Sweden